Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
44.79
+2.28 (5.36%)
Jan 30, 2025, 4:00 PM EST - Market closed
Janux Therapeutics Analyst Ratings
Total Analysts
11
Consensus Rating
Strong Buy
Price Target
$83.09
Upside
+85.51%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $200 | Buy | Reiterates | $200 | +346.53% | Dec 11, 2024 |
| Scotiabank | Scotiabank | Hold Maintains $42 → $62 | Hold | Maintains | $42 → $62 | +38.42% | Dec 4, 2024 |
| Stifel | Stifel | Strong Buy Maintains $70 → $115 | Strong Buy | Maintains | $70 → $115 | +156.75% | Dec 3, 2024 |
| Leerink Partners | Leerink Partners | Buy Maintains $79 → $91 | Buy | Maintains | $79 → $91 | +103.17% | Dec 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $63 → $70 | Strong Buy | Maintains | $63 → $70 | +56.28% | Dec 3, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $79 | Buy | Initiates | $79 | +76.38% | Nov 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $63 | Strong Buy | Reiterates | $63 | +40.66% | Nov 7, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $100 | Buy | Reiterates | $100 | +123.26% | Nov 7, 2024 |
| UBS | UBS | Strong Buy Initiates $69 | Strong Buy | Initiates | $69 | +54.05% | Oct 24, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $100 | Buy | Reiterates | $100 | +123.26% | Sep 16, 2024 |
| Stifel | Stifel | Strong Buy Initiates $70 | Strong Buy | Initiates | $70 | +56.28% | Sep 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $63 | Strong Buy | Reiterates | $63 | +40.66% | Aug 19, 2024 |
| Scotiabank | Scotiabank | Hold Maintains $47 → $42 | Hold | Maintains | $47 → $42 | -6.23% | Aug 9, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $100 | Buy | Reiterates | $100 | +123.26% | Aug 8, 2024 |
| Wedbush | Wedbush | Buy Reiterates $74 | Buy | Reiterates | $74 | +65.22% | Aug 8, 2024 |
| Scotiabank | Scotiabank | Hold Initiates $47 | Hold | Initiates | $47 | +4.93% | May 30, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.